PET/CT scans
PET/CT scans is an intervention with 10 clinical trials. Currently 4 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
4
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors
FAP-targeted PET/NIR in Lung Malignant Tumors
Imaging With a PET Agent for Detection of Cancers of the Head and Neck
Integrin αvβ6-targeted PET in Malignant Tumors
First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal Antibody
Clinical Trials (10)
Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors
FAP-targeted PET/NIR in Lung Malignant Tumors
Imaging With a PET Agent for Detection of Cancers of the Head and Neck
Integrin αvβ6-targeted PET in Malignant Tumors
First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal Antibody
Assessment of Treatment Response of Nasopharyngeal Cancer Using Simultaneous 18F-FDG-PET and MRI
PET CT Re-Planning NSCLC (4DCT-PET)
A Study to Assess Thymic Function Using PET/CT and MRI
Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy
PEARL PET-based Adaptive Radiotherapy Clinical Trial
All 10 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 10